US Patent 11179329 Therapeutical use of H3-ligands
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+207 characters)
Article
Patent abstract
The present invention concerns new therapeutical uses, including low dosage administration of the highly potent H3-ligand: (3S)-4-{4-[3-(3-methylpiperidin-1-yl)propoxy]phenyl}pyridine 1-oxide.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Jean-Charles Schwartz0
Jeanne-Marie Lecomte0
Marc Capet0
Olivier Labeeuw0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
111793290
Date of Patent
November 23, 2021
0Patent Application Number
164961260
Date Filed
March 21, 2018
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 11179329 Therapeutical use of H3-ligands
Infobox
Is a
Patent jurisdiction
Patent number
11179329
Date of patent
November 23, 2021
Patent application number
16496126
Date Filed
March 21, 2018
Patent primary examiner
Find more entities like US Patent 11179329 Therapeutical use of H3-ligands
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
